Cargando…
SAT-141 Effect of Vildagliptin versus Glibenclamide on Glycemic Variability and Endothelial Function in Individuals with Type 2 Diabetes and Hypertension: A Randomized Controlled Trial
Introduction: Glycemic variability has been considered as an important factor in the development of cardiovascular disease (CVD) in type 2 diabetes mellitus (T2DM). High glycemic variability causes endothelial dysfunction and increased oxidative stress. Among the drugs for T2DM, dipeptidyl peptidase...
Autores principales: | Cosenso-Martin, Luciana, Takaoka, Lais, Vilela-Martin, Jose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551825/ http://dx.doi.org/10.1210/js.2019-SAT-141 |
Ejemplares similares
-
Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension
por: Cosenso-Martin, Luciana Neves, et al.
Publicado: (2020) -
SAT-136 Investigation of Glycemic State among Responders to Hepatitis C Treatment
por: Elamir, Yasmine, et al.
Publicado: (2019) -
SAT-637 Patient-Centered Glycemic Management of Type 2 Diabetes with Mobile Applications
por: Lau, Chap-Kay K, et al.
Publicado: (2020) -
SAT-145 Insulin Technique Assessment and Its Association with Glycemic Control amongst Inpatients with Diabetes
por: Gulati, Neha, et al.
Publicado: (2019) -
SAT-640 Glycemic Profile of Intravenous Glucocorticoid Induced Hyperglycemia Using Continuous Glucose Monitoring
por: Zhang, Fan, et al.
Publicado: (2020)